IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 52.07

Change

+1.13 (+2.22)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+1.84 (+1.27%)

USD 37.98B
FHLC Fidelity® MSCI Health Care In..

+0.94 (+1.38%)

USD 2.70B
FXH First Trust Health Care AlphaD..

+1.73 (+1.67%)

USD 1.01B
XHE SPDR® S&P Health Care Equipme..

+1.51 (+1.83%)

USD 0.18B
IDNA iShares Genomics Immunology an..

+0.23 (+1.05%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF

+0.57 (+1.85%)

USD 0.09B
XHS SPDR® S&P Health Care Service..

+1.67 (+1.75%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

+0.38 (+1.36%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

+1.41 (+2.35%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.19 (+0.93%)

USD 6.67M

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 10.16 % 0.00 %

+0.43 (+1.59%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.50% 100% F 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.50% 100% F 85% B
Trailing 12 Months  
Capital Gain -2.84% 24% F 31% F
Dividend Return 0.77% 63% D 12% F
Total Return -2.07% 24% F 26% F
Trailing 5 Years  
Capital Gain 78.36% 90% A- 53% F
Dividend Return 7.14% 63% D 12% F
Total Return 85.50% 86% B+ 44% F
Average Annual (5 Year Horizon)  
Capital Gain 4.73% 62% D 50% F
Dividend Return 5.37% 62% D 44% F
Total Return 0.65% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 21.52% 43% F 50% F
Risk Adjusted Return 24.97% 57% F 39% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.